Science Explorer Back to mapMap
Discussion
Researcher · Fate Therapeutics (United States) · United States

Raedun L. Clarke

Raedun L. Clarke publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as CAR-T cell therapy research, CRISPR and Genetic Engineering and Pluripotent Stem Cells Research.

ORCID 0000-0002-1626-1358 OpenAlex
World rank
#2,053,324
of 7,710,434 ranked researchers
Rank in United States
#621,490
of 1,627,098
Works
45
Citations
904
Citations per work
20.1
h-index
11
i10-index 13Top 71% in Molecular Biology
Raedun L. Clarke

What does Raedun L. Clarke research?

Raedun L. Clarke's work is mostly in Biochemistry, Genetics and Molecular Biology (39%), Medicine (31%), Immunology and Microbiology (16%).

Life Sciences: 25 works · 54.8% of their workBiochemistry, Genetics and Molecular Biology: 18 works · 39.1% of their workMolecular Biology: 16 works · 34.8% of their workCell Biology: 2 works · 4.3% of their workImmunology and Microbiology: 7 works · 15.7% of their workImmunology: 7 works · 15.7% of their workHealth Sciences: 14 works · 31.3% of their workMedicine: 14 works · 31.3% of their workOncology: 14 works · 31.3% of their workPhysical Sciences: 3 works · 7.0% of their workEngineering: 3 works · 7.0% of their workBiomedical Engineering: 2 works · 3.5% of their workElectrical and Electronic Engineering: 2 works · 3.5% of their workEverything else: 3 works · 6.9% of their workTHEIR WORKRaedun L. Clarke45works
Life Sciences55%Physical Sciences7%Health Sciences31%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1839.1%
    2. Immunology and Microbiology715.7%
    1. Medicine1431.3%
    1. Engineering37.0%
  4. Everything else36.9%
  1. 1Molecular Biology35% of their works
  2. 2Oncology31% of their works
  3. 3Immunology16% of their works
  4. 4Cell Biology4% of their works
  5. 5Biomedical Engineering4% of their works
  6. 6Electrical and Electronic Engineering4% of their works

Research topics

Which keywords describe Raedun L. Clarke's research?

The keywords of their largest research topics: Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Genome Engineering, RNA-Guided, Induced Pluripotent Stem Cells, Pluripotent Stem Cells and Natural Killer Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer Immunotherapy382 topics
  2. CAR T Cells351 topic
  3. Chimeric Antigen Receptor351 topic
  4. Genome Engineering201 topic
  5. RNA-Guided201 topic
  6. Induced Pluripotent Stem Cells121 topic
  7. Pluripotent Stem Cells121 topic
  8. NK Cell Recognition91 topic
  9. Natural Killer Cells91 topic
  10. Model Organism51 topic
  11. Zebrafish51 topic
  12. Nanowire Transistors41 topic
  13. Tunnel Field-Effect Transistors41 topic
  14. Dendritic Cells31 topic
  15. Immunity31 topic
  16. Mammalian Cells31 topic
  17. Recombinant Protein31 topic

Where does Raedun L. Clarke work?

Raedun L. Clarke's main affiliation in the publication record is Fate Therapeutics (United States), United States.

How many publications and citations does Raedun L. Clarke have?

OpenAlex counts 45 works and 904 citations for Raedun L. Clarke, an h-index of 11, ranking #2,053,324 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Raedun L. Clarke. Posts are plain text and can be reported.